240
Views
13
CrossRef citations to date
0
Altmetric
Research Articles

Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage

, , , , &

References

  • Allison JL, Shust DJ. 2009. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Current Opinion in Endocrinology, Diabetes and Obesity 16:446–450.
  • Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O et al. 2007. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss. Data from the southeast of Turkey. Annals of Hematology 86:727–731.
  • Altomare I, Adler A, Aledort LM. 2007. The 5,10 methylenetetrahydrofolate reductase C677T mutation and the risk of fetal loss: a case series and review of the literature. Thrombosis Journal 5:17.
  • Baek KH, Lee EJ, Kim YS. 2007. Recurrent pregnancy loss: the key potential mechanisms. Trends in Molecular Medicine 13:257–267.
  • Biswas A, Choudhry P, Mittal A, Meena A, Ranjan R, Choudhry VP et al. 2008. Recurrent abortions in Asian Indians: no role of factor V Leiden Hong Kong/Cambridge mutation and MTHFR polymorphism. Clinical and Applied Thrombosis/Hemostasis 14:102–104.
  • Christiansen OB, Nybo Andersen AM, Bosh E, Daya S, Delves PJ, Hviid TV et al. 2005. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertility and Sterility 83:821–839.
  • Christiansen OB, Steffenson R, Nielsen H, Varming K. 2008. Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications. Gynecologic and Obstetric Investigation 66:257–267.
  • Coulam CB, Jeyendran RS, Fishel LA, Roussev R. 2006. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. American Journal of Reproductive Immunology 55:360–368.
  • Coulam CB, Wallis D, Weinstein J, DasGupta DS, Jeyendran RS. 2008. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. American Journal of Reproductive Immunology 60:426–431.
  • Di Micco P, D'Uva M, Strina I, De Placido G, Di Fiore R, Quaranta S et al. 2007. Recurrent pregnancy loss and thrombophilia. Clinical Laboratory 553:309–314.
  • D’Uva M, Di Micco P, Strina I, Ranieri A, Alviggi C, Mollo A et al. 2008. Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy. Biologics 2:897–902.
  • Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T et al. 2001. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism pooled analysis of 8 case–control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Thrombosis and Haemostasis 86:809–816.
  • Glueck CJ, Gogenini S, Munjal J, Tracy T, Pranikoff J, Wang P. 2008. Factor V Leiden mutation: a treatable etiology for sporadic and recurrent pregnancy loss. Fertility and Sterility 89:410–416.
  • Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R. 2006. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss?American Journal of Reproductive Immunology 56:230–236.
  • Goodmann C, Hur J, Goodman CS, Jeyendran RS, Coulam C. 2009. Are polymorphisms in the ACE and PAI-1 associated with recurrent spontaneous miscarriages?American Journal of Reproductive Immunology 62:365–370.
  • Govindaiah V, Naushad SM, Prabhakara K, Krishna PC, Radha Rama Devi A. 2009. Association of parental hyperhomocysteinemia and C677T Methylene tetrahydrofolate reductase (MTHFR) polymorphism with recurrent pregnancy loss. Clinical Biochemistry 42:380–386.
  • Grandone E, Colaiazzo D, Tiscia G, Vergura P, Cappucci F, Greco L et al. 2011. Impact of common thrombophilias and Jak2 V617F on pregnancy outcomes in unselected Italian women. Journal of Thrombosis and Haemostasis 9:496–501.
  • Gris JC, Schved JF, Neveu S, Mares P, Aguilar-Martinez P, Dupaigne D. 1990. Impaired fibrinolytic capacity and early recurrent spontaneous abortion. British Medical Journal 300:1500.
  • Gris JC, Neveu S, Mares P, Biron C, Hedon B, Scheved JF. 1993. Plasmafibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. Journal of Laboratory and Clinical Medicine 22:606–615.
  • Gumpel C, Fornasiero L, Suarez S, Santillan G, Colabianchi C. 2009. PAI-1 45/5G polymorphism detection and obstetric complications. Thrombosis Research 123:S148.
  • Ivanov PD, Komsa-Penkova RS, Konova EI, Kovacheva KS, Simeonova MN, Popov JD. 2009. Association of inherited thrombophilia with embryonic and postembryonic recurrent pregnancy loss. Blood Coagulation and Fibrinolysis 20:134–140.
  • Jaslow CR, Carney JL, Kutteh WH. 2009. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertility and Sterility 93:1234–1243.
  • Jivrai S, Rai R, Underwood J, Regan L. 2006. Genetic thrombophilic mutations among couples with recurrent miscarriage. Human Reproduction 21:1161–1165.
  • Jivraj S, Makris M, Saravelos S, Li TC. 2009. Pregnancy outcome in women with factor V Leiden and recurrent miscarriage. British Journal of Obstetrics and Gynaecology 116:995–998.
  • Krabbendam I, Franx A, Bots ML, Fijnheer R, Bruinse HW. 2005. Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature. European Journal of Obstetrics, Gynecology, and Reproductive Biology 118:143–153.
  • Kwak-Kim J, Yang KM, Gilman-Sachs A. 2009. Recurrent pregnancy loss: a disease of inflammation and coagulation. Journal of Obstetrics and Gynaecology Research 35:609–622.
  • Lala PK, Graham CH. 1990. Mechanisms of trophoblast invasiveness and their control: the role of proteases and protease inhibitors. Cancer and Metastasis Reviews 9:369–379.
  • Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR et al. 2010. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation 121:1706–1712.
  • Lindhoff-Last E, Luxembourg B. 2008. Evidence-based indications for thrombophilia screening. VASA. Zeitschrift für Gefässkrankheiten 37:19–30.
  • Lopez-Alemany R, Redondo JM, Nagamine Y, Munoz-Canoves P. 2003. Plasminogen activator inhibitor type-1 inhibits insulin signalling by competing with alphabeta3 integrin for vitronectin binding. European Journal of Biochemistry 270:814–821.
  • Lund M, Nielsen HS, Hviid TV, Steffensen R, Nyboe Andersen A, Christiansen OB. 2010. Hereditary thrombophilia and recurrent pregnancy loss: a retrospective cohort study of pregnancy outcome and obstetric complications. Human Reproduction 25:2978–2984.
  • Masini S, Ticconi C, Gravina P, Tomassini M, Pietropolli A, Forte V et al. 2009. Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss. Fertility and Sterility 92:694–702.
  • Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K et al. 2001. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis. Blood Coagulation and Fibrinolysis 12:713–720.
  • Morales-Machín A, Borjas-Fajardo L, Quintero JM, Zabala W, Alvarez F, Delgado W et al. 2009. C677T polymorphism of the methylenetetrahydrofolate reductase gene as risk factor in women with recurrent abortion. Investigacion Clinica 50:327–333.
  • Pasquier E, Bohec C, Mottier D, Jaffuel S, Mercier B, Férec C et al. 2009. Inherited thrombophilias and unexplained pregnancy loss: an incident case-control study. Journal of Thrombosis and Haemostasis 7:306–311.
  • Patnaik MM, Haddad T, Morton CT. 2007. Pregnancy and thrombophilia. Expert Review of Cardiovascular Therapy 5:753–765.
  • Pihusch R, Buchholz T, Lohse P, Rübsamen H, Rogenhofer N, Hasbargen U et al. 2001. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. American Journal of Reproductive Immunology 46:124–131.
  • Preston FE, Rosendaal FR, Walker ID, Briët E, Berntorp E, Conard J et al. 1996. Increased fetal loss in women with heritable thrombophilia. Lancet 348:913–916.
  • Ren A, Wang J. 2006. Methylentetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis. Fertility and Sterility 86:1716–1722.
  • Rey E, Kahn SR, David M, Shrier I. 2003. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361:901–908.
  • Salafia C, Maier D, Vogel C, Pezzullo J, Burns J, Silberman L. 1993. Placental and decidual histology in spontaneous abortion: detailed description and correlations with chromosome number. Obstetrics and Gynecology 82:295–303.
  • Soltanghoraee H, Memariani T, Aarabi M, Hantoushzadeh S, Arefi S, Arabi M et al. 2007. Association of ACE, PAI-1 and coagulation factor XIII gene polymorphisms with recurrent spontaneous abortion in Iranian patients. Journal of Reproduction and Infertility 7:324–330.
  • Sottilotta G, Oriana V, Latella C, Luise F, Piromalli A, Ramirez F et al. 2006. Genetic prothrombotic risk factors in women with unexplained pregnancy loss. Thrombosis Research 1117:681–684.
  • Sun L, Lv H, Wei W, Zhang D, Guan Y. 2009. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortion in women with polycystic ovarian syndrome. Journal of Endocrinological Investigation 33:77–82.
  • Ticconi C, Rotondi F, Veglia M, Pietropolli A, Bernardini S, Ria F et al. 2010. Antinuclear autoantibodies in women with recurrent pregnancy loss. American Journal of Reproductive Immunology 64:384–392.
  • Ticconi C, Mancinelli F, Gravina P, Federici G, Piccione E, Bernardini S. 2011. Beta-Fibrinogen G-455A polymorphisms and recurrent miscarriage. Gynecologic and Obstetric Investigation 71:198–201.
  • Vettriselvi V, Vijayalakshimi K, Paul SF, Venkatachalam P. 2008. Ace and MTHFR gene polymorphisms in unexplained recurrent pregnancy loss. Journal of Obstetrics and Gynaecology Research 34:301–306.
  • Wolf CE, Haubelt H, Pauer HU, Hinney B, Krome-Cesar C, Lagler TJ et al. 2003. Recurrent pregnancy loss and its relation to FV Leiden, FII G20210A and polymorphisms of plasminogen activator and plasminogen activator inhibitor. Pathophysiology of Haemostasis and Thrombosis 33:134–137.
  • Zoller B, Dahlback B. 1994. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343:1536–1538.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.